問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberNANORAY-312
Active

2022-01-31 - 2028-09-30

Phase III

Recruiting5

ICD-10C14.0

Malignant neoplasm of pharynx, unspecified

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9149.0

Malignant neoplasm of pharynx, unspecified

  • Trial Applicant

    Johnson & Johnson

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/02/01

Investigators and Locations

Principal Investigator 林進清 Division of Radiation Therapy

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Shang-Yin Wu Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Hsiang-Fong Kao Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 劉怡君 Division of Radiation Therapy

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    15 participants

  • Global

    500 participants